Viewing Study NCT04028050


Ignite Creation Date: 2025-12-24 @ 4:56 PM
Ignite Modification Date: 2026-02-25 @ 4:48 PM
Study NCT ID: NCT04028050
Status: COMPLETED
Last Update Posted: 2024-07-16
First Post: 2019-07-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module